Directorio de personas
Dolors Cuevas Sanchez

Dolors Cuevas Sanchez

Grado: Doctor/a


mcuevas(ELIMINAR)@gss.cat

Grupos

Publicaciones

  • Dorca, E; Velasco, A; Varela, M; Gatius, S; Villatoro, S; Fullana, N; Cuevas, D; Vaquero, M; Birnbaum, A; Neumann, K; Matias-Guiu, X

    Validation of Modaplex POLE mutation assay in endometrial carcinoma

    VIRCHOWS ARCHIV 483 787-794. .

    [doi:10.1007/s00428-023-03636-0]

  • MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

    Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

    ACTA DERMATO-VENEREOLOGICA 101 -. .

    [doi:10.2340/actadv.v101.361]

  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Cuevas, D; Velasco, A; Vaquero, M; Santacana, M; Gatius, S; Eritja, N; Estaran, E; Matias-Guiu, X

    Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY.

    Histopathology 76 447-460. .

    [doi:10.1111/his.14001]

  • Cuevas, D; Valls, J; Gatius, S; Roman-Canal, B; Estaran, E; Dorca, E; Santacana, M; Vaquero, M; Eritja, N; Velasco, A; Matias-Guiu, X

    Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    VIRCHOWS ARCHIV 474 585-598. .

    [doi:10.1007/s00428-018-02516-2]

  • Davidson, B; Pinamonti, M; Cuevas, D; Holth, A; Zeppa, P; Hager, T; Wohlschlaeger, J; Tötsch M

    The diagnostic role of PTEN and ARID1A in serous effusions

    VIRCHOWS ARCHIV 472 425-432. .

    [doi:10.1007/s00428-017-2273-1]

  • Gatius, S; Cuevas, D; Fernandez, C; Roman-Canal, B; Adamoli, V; Piulats, JM; Eritja, N; Martin-Satue, M; Moreno-Bueno, G; Matias-Guiu, X

    Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology 85 35-40. .

    [doi:10.1159/000475529]

  • Del Carmen S; Gatius S; Franch-Arcas G; Baena JA; Gonzalez O; Zafon C; Cuevas D; Valls J; Pérez A; Martinez M; Ros S; Macías CG; Iglesias C; Matías-Guiu X; de Álava E

    Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid

    HUMAN PATHOLOGY 48 132-141. .

    [doi:10.1016/j.humpath.2015.09.020]

  • Maiques, O.; Cuevas, D.; García Dios, D.A.; Coenegrachts, L.; Santacana, M.; Velasco, A.; Romero, M.; Gatius, S.; Lambrechts, D.; Müller, S.; Pedersen, H.C.; Dolcet, X.; Amant, F.; Matias-Guiu, X.

    FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA

    Histopathology 65 371-388. .

    [doi:10.1111/his.12396]

  • Vilardell, Felip; Novell, Anna; Martin, Javier; Santacana, Maria; Velasco, Ana; Diez-Castro, M. J.; Cuevas, Dolors; Jose Panades, M.; Gonzalez, Serafin; Llombart, Antonio; Iglesias, Edelmiro; Matias-Guiu, Xavier

    Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

    VIRCHOWS ARCHIV 460 569-575. .

    [doi:10.1007/s00428-012-1241-z]

  • Vilardell, F.; Velasco, A.; Cuevas, D.; Olsina, J. J.; Matias-Guiu, X.

    Composite papillary intestinal-type adenocarcinoma/poorly differentiated neuroendocrine carcinoma of the ampulla of Vater

    JOURNAL OF CLINICAL PATHOLOGY 64 174-177. .

    [doi:10.1136/jcp.2010.084954]

  • Pallares, Judit; Llobet, David; Santacana, Maria; Eritja, Nuria; Velasco, Ana; Cuevas, Dolors; Lopez, Susana; Palomar-Asenjo, Victor; Yeramian, Andree; Dolcet, Xavier; Matias-Guiu, Xavier

    CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

    AMERICAN JOURNAL OF PATHOLOGY 174 287-296. .

    [doi:10.2353/ajpath.2009.080552]

Proyectos

  • Analysis Of Molecular Alterations And Therapeutic Targets For P53/Pten-Deficient Endometrial Cancers.
  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
  • MECANISMOS DE REGULACION FLIP Y LA RESPUESTA A TRAIL EN EL DESARROLLO Y PROGRESION DEL CANCER